Cell therapies in bladder cancer management
L Morales, JM Paramio - International Journal of Molecular Sciences, 2021 - mdpi.com
Currently, bladder cancer (BC) represents a challenging problem in the field of Oncology.
The high incidence, prevalence, and progression of BC have led to the exploration of new …
The high incidence, prevalence, and progression of BC have led to the exploration of new …
[HTML][HTML] Immune checkpoint inhibitors in the management of urothelial carcinoma
A Patel, DI Bisno, HV Patel… - Journal of cancer …, 2021 - ncbi.nlm.nih.gov
Urothelial carcinoma is one of the most common cancers in the United States, yet outcomes
are historically suboptimal. Since 2016, the approval of five programmed cell death 1 and …
are historically suboptimal. Since 2016, the approval of five programmed cell death 1 and …
Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical …
J Aumatell, J Huguet, JD Subiela, JM Gaya… - … Oncology: Seminars and …, 2021 - Elsevier
Objectives To assess whether the use of endoscopic exploration (EE) as a routine
diagnostic tool in patients with clinical suspicion of upper tract urothelial carcinoma (UTUC) …
diagnostic tool in patients with clinical suspicion of upper tract urothelial carcinoma (UTUC) …